Those two articles were trending today on a websit
Post# of 148365
Not sure about the correct percentage, but I noticed for the 10%, they say 10% even though they take their daily pills and are not saddled with drug-resistant mutants of the virus
I wonder what leronlimab would do with these group that have ccr5 version. We know a couple in the combo study was in this group and leronlimab worked when no other hiv drug had worked before. I assume if they were mdr2 or mdr3, 20+ years on hiv, they probably tried many others.